GlassScriptPhysician profile
Brandon W Sur
NPI 1518227180
$1,574.81
in general payments reported to CMS, 2019-2025
10 companies · $96.53 in 2025
The $96.53 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.06 · 2020: $31.21 · 2022: $1,135 · 2023: $237 · 2024: $40.17 · 2025: $96.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $1,139.77 | 2019-2022 | |
| Inari Medical, INC. | $106.42 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $98.54 | 2023 | Indigo System |
| Stryker Corporation | $96.53 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Boston Scientific Corporation | $40.17 | 2024 | Wavewriter Alpha Prime 16 |
| Terumo Medical Corporation | $31.21 | 2020 | |
| Teleflex LLC | $19.34 | 2023 | Arrow |
| Bigfoot Biomedical INC | $16.41 | 2022 | |
| Novo Nordisk INC | $13.33 | 2019 | |
| Bard Peripheral Vascular, INC. | $13.09 | 2023 | Denali Vena Cava Filter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Sur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.